Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Movano ( (MOVE) ) has shared an announcement.
Movano Health announced a 1-for-10 reverse stock split of its common stock, effective October 10, 2025, to comply with Nasdaq’s minimum bid price requirement. This move will reduce the number of outstanding shares from approximately 8.3 million to 0.8 million, while maintaining the number of authorized shares, and aims to enhance the company’s market positioning.
The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.
Spark’s Take on MOVE Stock
According to Spark, TipRanks’ AI Analyst, MOVE is a Underperform.
Movano’s stock faces significant challenges primarily due to its weak financial performance, marked by negative profitability and cash flow issues. The technical analysis indicates a bearish trend with poor market momentum, and valuation metrics are unfavorably low. Overall, the stock needs substantial improvement in operational efficiency and market perception to enhance its attractiveness.
To see Spark’s full report on MOVE stock, click here.
More about Movano
Founded in 2018, Movano Inc., operating as Movano Health, is a company focused on developing healthcare solutions that integrate medical-grade data into wearable devices. Their flagship product, the Evie Ring, exemplifies their commitment to providing modern, flexible, and innovative approaches to health data management, aimed at offering personalized and intelligent health insights.
Average Trading Volume: 2,719,279
Technical Sentiment Signal: Sell
Current Market Cap: $5.76M
For a thorough assessment of MOVE stock, go to TipRanks’ Stock Analysis page.